Susan Cantin

Susan Cantin is currently employed as an Associate Director In Vivo Biology at Jnana Therapeutics. Previously, they have held positions such as Principal Scientist at Xilio Therapeutics, Sr. Scientist at AstraZeneca, and Scientist at Celgene Corporation. They have a background in biology, with a MA from Harvard University and a BS in Zoology from the University of Massachusetts Amherst. Their experience includes working on various research projects involving animal models, drug candidates, and immunoconjugates in companies such as Hydra Biosciences, Diaiichi Asubio Medical Research Laboratories, Praecis Pharmaceuticals, and ImmunoGen, Inc.